A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Exact Sciences Corp stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 6,166 shares of EXAS stock, worth $358,306. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,166
Previous 7,658 19.48%
Holding current value
$358,306
Previous $324,000 29.63%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$42.43 - $70.83 $63,305 - $105,678
-1,492 Reduced 19.48%
6,166 $420,000
Q2 2024

Jul 29, 2024

SELL
$41.33 - $74.26 $147,920 - $265,776
-3,579 Reduced 31.85%
7,658 $324,000
Q1 2024

May 08, 2024

SELL
$56.27 - $73.77 $694,034 - $909,879
-12,334 Reduced 52.33%
11,237 $776,000
Q4 2023

Feb 09, 2024

BUY
$59.06 - $75.72 $681,316 - $873,505
11,536 Added 95.85%
23,571 $1.74 Million
Q3 2023

Nov 13, 2023

BUY
$65.94 - $99.04 $11,341 - $17,034
172 Added 1.45%
12,035 $821,000
Q2 2023

Aug 08, 2023

SELL
$62.68 - $95.05 $9,715 - $14,732
-155 Reduced 1.29%
11,863 $1.11 Million
Q1 2023

May 08, 2023

BUY
$47.19 - $70.77 $16,941 - $25,406
359 Added 3.08%
12,018 $815,000
Q4 2022

Feb 09, 2023

BUY
$30.35 - $53.15 $353,850 - $619,675
11,659 New
11,659 $577,000
Q2 2022

Aug 04, 2022

BUY
$35.61 - $76.23 $787,123 - $1.68 Million
22,104 Added 469.3%
26,814 $1.06 Million
Q1 2022

May 12, 2022

BUY
$57.56 - $82.54 $49,501 - $70,984
860 Added 22.34%
4,710 $329,000
Q4 2021

Feb 09, 2022

BUY
$72.5 - $100.68 $279,125 - $387,618
3,850 New
3,850 $300,000
Q3 2021

Nov 08, 2021

SELL
$90.24 - $124.05 $145,196 - $199,596
-1,609 Closed
0 $0
Q2 2021

Aug 05, 2021

BUY
$93.66 - $139.27 $150,698 - $224,085
1,609 New
1,609 $200,000
Q3 2020

Nov 09, 2020

SELL
$72.92 - $102.01 $169,976 - $237,785
-2,331 Closed
0 $0
Q2 2020

Aug 04, 2020

BUY
$55.75 - $92.75 $129,953 - $216,200
2,331 New
2,331 $203,000
Q1 2020

May 12, 2020

SELL
$37.9 - $104.44 $88,344 - $243,449
-2,331 Closed
0 $0
Q4 2019

Feb 11, 2020

SELL
$77.66 - $99.74 $50,168 - $64,432
-646 Reduced 21.7%
2,331 $216,000
Q3 2019

Nov 12, 2019

SELL
$90.37 - $122.49 $30,545 - $41,401
-338 Reduced 10.2%
2,977 $269,000
Q2 2019

Aug 02, 2019

BUY
$89.51 - $118.04 $296,725 - $391,302
3,315 New
3,315 $391,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.3B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Bnp Paribas Asset Management Holding S.A. Portfolio

Follow Bnp Paribas Asset Management Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bnp Paribas Asset Management Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Bnp Paribas Asset Management Holding S.A. with notifications on news.